A PHASE II DOUBLE-BLIND VEHICLE-CONTROLLED CROSSOVER SINGLE DOSE (400 µG) V0147 GEL EFFECT AND TOLERANCE STUDY IN SPINAL CORD INJURED PATIENTS WITH ERECTILE DYSFUNCTION

Registry ID

EUCTR2007-001058-16

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE2

Sponsor

PIERRE FABRE MEDICAMENT

Start date

2007-04-30

Last update

2026-08-16

Conditions

• Erectile dysfunction

Summary

The main objective of the study is to assess the ability of a single dose of 400 µg V0147 gel versus vehicle applied locally to induce an erectile response in spinal cord injured patients with erectile dysfunction.

Locations

• , , France

View on source registry